Today: 29 April 2026
Cadence Bank stock price: CADE frozen after Huntington takeover, focus shifts to HBAN
6 February 2026
2 mins read

Cadence Bank stock price: CADE frozen after Huntington takeover, focus shifts to HBAN

New York, Feb 6, 2026, 08:05 EST — Premarket

  • Shares of Cadence Bank last traded at $42.11 on Jan. 30, before the stock was halted
  • A filing reveals that each Cadence share will convert into a fixed 2.475 shares of Huntington.
  • Investors are focused on Huntington’s next steps after the deal and its February 10 appearance at a UBS conference

Cadence Bank shares remained frozen on Friday following a trading halt by the New York Stock Exchange. The stock last closed at $42.11 on Jan. 30, slipping 1.66%. Meanwhile, Huntington Bancshares, the acquirer, dipped to $19.02 in premarket action.

The halt is crucial for Cadence shareholders since the stock is no longer trading actively but represents a corporate-action calculation. According to an SEC filing from Huntington, each Cadence common share was converted into the right to receive 2.475 shares of Huntington common stock—a fixed “exchange ratio.” This means the value now hinges entirely on HBAN’s stock price. Huntington Bancshares Incorporated

Now that the deal is sealed, attention shifts to Huntington’s next moves — particularly how smoothly it can absorb a large Southern presence without unexpected hits to credit or costs.

On Wednesday, Huntington announced it has chosen Ameriprise Financial Services as its new retail investment program provider. The move shifts support for its brokerage, advisory, and insurance services over to Ameriprise’s financial institutions unit. Huntington Financial Advisors, the bank said, has roughly 260 advisors managing close to $28 billion. “As we look to the future, we are focused on driving sustainable growth,” said Melissa Holding, head of Huntington wealth. Huntington Bancshares Incorporated

Huntington announced Thursday that Senthil Kumar will take over as chief risk officer starting Feb. 16, succeeding Helga Houston, who will shift to a senior executive advisor position. CEO Steve Steinour highlighted Kumar’s background as a boost to the bank’s risk management “as we enter the next phase of growth and innovation.” Huntington Bancshares Incorporated

Huntington finalized its merger with Cadence this month, announcing plans to convert Cadence customer accounts to Huntington systems by mid-2026. The bank confirmed it will maintain Cadence’s branch network without any closures. The merged entity is projected to hold around $279 billion in assets, based on Dec. 31, 2025 figures.

For former Cadence shareholders, the math is straightforward but harsh: their number of shares stays constant, while the value shifts with HBAN. That volatility can outweigh any news Cadence put out on its own before it stopped trading independently.

The familiar risk with bank mergers? Integration often drags — systems, staff, compliance all take longer than planned. Then, if credit conditions sour, earnings can falter just as management touts “growth” and scale.

Huntington’s next key event is its appearance at the UBS Financial Services Conference on Feb. 10, where CEO Steinour and CFO Zach Wasserman will take the stage. Investors want details on how the Cadence integration is progressing, the bank’s risk approach, and the expected pace of cost and revenue shifts now that CADE is no longer part of the equation.

Stock Market Today

  • Bill Ackman Launches $5 Billion Pershing Square IPO, Stays Bullish on Tech Stocks
    April 29, 2026, 12:31 PM EDT. Bill Ackman leads the dual IPO of Pershing Square Inc. and Pershing Square USA, raising $5 billion, supported by 85% institutional investors. The Pershing Square USA fund debuted at $50 on the NYSE. Ackman aims to build a diversified holding company through a $900 million stake in Howard Hughes Holdings, echoing Warren Buffett's Berkshire Hathaway model. The IPO includes a private placement securing $2.8 billion from family offices and pension funds. Ackman's portfolio continues to back the American consumer with bets on Restaurant Brands, Hilton (HLT), Alphabet (GOOGL), and Meta (META). Despite reports of OpenAI missing financial targets, he remains bullish on tech. Ackman also embraced a political shift, backing Trump due to deregulation and economic policies.

Latest article

Mastercard Stock Jumps Before Earnings as Visa’s Big Beat Sends a Fresh Signal

Mastercard Stock Jumps Before Earnings as Visa’s Big Beat Sends a Fresh Signal

29 April 2026
Mastercard shares climbed 3.8% to $526.90 Wednesday after Visa beat profit estimates and raised its outlook, sending Visa shares up 8.7%. Mastercard reports first-quarter results Thursday. The company expanded its Start Path program this week to focus on business payments, with fintech Glass joining to work on public-sector procurement. Mastercard does not lend or issue cards, earning mainly from transaction fees.
GE HealthCare Technologies Inc. Stock Sinks as Tariffs and Chip Costs Force Profit Cut

GE HealthCare Technologies Inc. Stock Sinks as Tariffs and Chip Costs Force Profit Cut

29 April 2026
GE HealthCare cut its 2026 profit forecast Wednesday, citing higher chip, oil, and freight costs, as well as tariffs and a supplier issue. Shares fell nearly 13% to $59.75. First-quarter revenue rose 7.4% to $5.13 billion, but net income dropped to $389 million from $564 million a year earlier. The company also announced a reorganization, merging its Imaging and Advanced Visualization units.
Applied Materials (AMAT) Faces Fresh China Shock After U.S. Targets Hua Hong Shipments

Applied Materials (AMAT) Faces Fresh China Shock After U.S. Targets Hua Hong Shipments

29 April 2026
The U.S. Commerce Department ordered Applied Materials, Lam Research, and KLA to halt some chip-tool shipments to China’s Hua Hong, Reuters reported. The move targets shipments linked to facilities believed capable of advanced chip production. Applied reported $2.10 billion in China revenue last quarter, or 30% of its total. Shares in Applied, Lam, and KLA traded lower after the news.
Coloplast A/S stock sinks nearly 8% as Medicare reimbursement change hits Kerecis outlook
Previous Story

Coloplast A/S stock sinks nearly 8% as Medicare reimbursement change hits Kerecis outlook

Ford stock slips before market open as EV sales dive and Geely talks linger
Next Story

Ford stock slips before market open as EV sales dive and Geely talks linger

Go toTop